Help

BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.

To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.

To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.

Employee Benefits

Rx price increases in 2021 lower than 2020, but not fully warranted: Study

December 07, 2022 Reprints

Pharmaceutical price increases 2021 that were behind an $805 million increase in U.S. spending from the prior year were not supported by clinical evidence, an influential U.S. pricing research firm says, reports Reuters. The Institute for Clinical and Economic Review said the spending increase in 2021 was still less than the $1.67 billion rise in the previous year.

1. Ozempic side-effect litigation may surge
2. Weight-loss drugs lead to higher health care costs for employers: Mercer
3. Weight-loss drugs drives health insurance fund $15M deficit
4. Some BCBS plans start offering direct health care delivery
5. 401(k) contribution rates decline in 2022: Report
6. Former NBA players Glen Davis and Will Bynum convicted in health care fraud case

Help

Rx price increases in 2021 lower than 2020, but not fully warranted: Study

Readers Poll

Most Read in Employee Benefits

Sign up now for free access to this article and much more.

If you are already registered with Business Insurance, click here to Login

Please tell us a bit more about yourself in order to continue

About

Advertise

Reprints and Licensing

Resources